| SE() | Adjusted odds ratio | p-value | |
---|---|---|---|---|
Duration of polypharmacy: Less than 30 days* | ||||
31- 90 days | 0.28 | 0.03 | 1.33 | <0.001 |
91 – 180 days | 0.50 | 0.03 | 1.65 | <0.001 |
Over 181 days | 0.55 | 0.03 | 1.74 | <0.001 |
Gender:Female* | ||||
Male | 0.28 | 0.02 | 1.32 | <0.001 |
Age:0-18 years old * | ||||
19-64 years old | 1.86 | 0.08 | 6.40 | <0.001 |
65-79 years old | 2.19 | 0.08 | 8.93 | <0.001 |
Over 80 years old | 2.67 | 0.08 | 14.46 | <0.001 |
ICUs | 1.48 | 0.02 | 4.37 | <0.001 |
Comorbidity | ||||
ASHD | −0.23 | 0.02 | 0.80 | <0.001 |
CHF | 0.67 | 0.03 | 1.95 | <0.001 |
CVA/TIA | 0.21 | 0.02 | 1.24 | <0.001 |
PVD | 0.14 | 0.04 | 1.15 | 0.001 |
Other cardiac | 0.08 | 0.03 | 1.09 | 0.006 |
COPD | −0.10 | 0.02 | 0.91 | <0.001 |
GI | 0.30 | 0.02 | 1.36 | <0.001 |
Liver disease | 0.15 | 0.02 | 1.16 | <0.001 |
Cancer | 0.65 | 0.02 | 1.92 | <0.001 |
Diabetes | 0.46 | 0.02 | 1.58 | <0.001 |
Site of operation | ||||
Nervous system | −0.82 | 0.07 | 0.44 | <0.001 |
Endocrine system | −2.25 | 0.26 | 0.11 | <0.001 |
Nose, mouth and pharynx | −0.58 | 0.14 | 0.56 | <0.001 |
Respiratory system | −0.30 | 0.03 | 0.75 | <0.001 |
Cardiovascular system | 0.38 | 0.02 | 1.47 | <0.001 |
Digestive system | 0.26 | 0.02 | 1.30 | <0.001 |
Urinary system | −0.21 | 0.03 | 0.81 | <0.001 |
Male genital organs | −1.38 | 0.54 | 0.25 | 0.010 |
Female genital organs | −2.63 | 1.01 | 0.07 | 0.009 |
Musculoskeletal system | −0.15 | 0.06 | 0.86 | 0.007 |
Integumentary system | 0.11 | 0.05 | 1.12 | 0.039 |
Miscellaneous diagnostic and therapeutic procedures | 0.35 | 0.02 | 1.42 | <0.001 |